Infusystems Holdings Inc. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Infusystems Holdings Inc. with three other
companies in this sector in the United States:
sales of $57.56 million
of which 69%
was Trauma and Deformity),
of which 100%
was Blood Safety), and
Antares Pharma, Inc.
of which 48%
was Partnered product sales).
During the year ended December of 2018, sales at
Infusystems Holdings Inc. were $67.14 million.
decrease of 5.5%
versus 2017, when the company's sales were $71.08 million.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Infusystems Holdings Inc. had sales
of $62.28 million.